Yes, lncRNAs hold great potential as biomarkers for cancer diagnosis, prognosis, and therapeutic response. Their expression patterns can be highly specific to certain cancer types or stages, making them valuable for early detection and monitoring disease progression. For example, elevated levels of the lncRNA MALAT1 are associated with poor prognosis in lung cancer.
